Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis
β Scribed by Shan Kang; Jian Zhao; Qing Liu; Rongmiao Zhou; Na Wang; Yan Li
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 94 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0893-6692
- DOI
- 10.1002/em.20455
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Vascular endothelial growth factor (VEGF), the key mediator of angiogenesis, plays an important role in the development of different kind of tumors, including gastric cancer (GC). The aim of this study is to test the hypothesis that genetic variants of __VEGF__ are associated with risk
## Abstract A common 936 C/T polymorphism in the gene for the vascular endothelial growth factor (VEGF) has been associated with VEGF plasma levels. In our caseβcontrol study, we investigated the role of this polymorphism for breast cancer risk. VEGF genotype was determined in 500 women with breast
## Abstract Angiogenesis plays an important role in growth, progression, and metastasis of tumors. The most important regulator of angiogenesis is vascular endothelial growth factor (VEGF). __VEGF__ expression has been associated with advance stage and poor survival of several cancers. In the prese
## Abstract ## BACKGROUND The vascular endothelial growth factor (VEGF) family and VEGF receptors (VEGFR) play an essential role in the angiogenesis of both pathologic and nonpathologic conditions. However, the prognostic significance of VEGF and VEGFR expression in ovarian carcinoma is unclear.